Cite
Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
MLA
Xiangbin Wang, et al. “Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery.” Journal of Immunology Research, vol. 2023, Jan. 2023. EBSCOhost, https://doi.org/10.1155/2023/7612566.
APA
Xiangbin Wang, Shan Li, Rui Zhao, Huijun Li, Peng Gao, Cuicui Jin, Cong Fang, Yongping Liu, Ailian Hei, Ji Zhou, Jin Li, Ellen He, & Sven Skog. (2023). Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery. Journal of Immunology Research, 2023. https://doi.org/10.1155/2023/7612566
Chicago
Xiangbin Wang, Shan Li, Rui Zhao, Huijun Li, Peng Gao, Cuicui Jin, Cong Fang, et al. 2023. “Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery.” Journal of Immunology Research 2023 (January). doi:10.1155/2023/7612566.